ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $43,696,000 | +8.9% | 3,512,570 | +19.9% | 0.04% | +5.9% |
Q3 2016 | $40,112,000 | +1038.9% | 2,930,036 | +514.8% | 0.03% | +1033.3% |
Q2 2016 | $3,522,000 | +61.0% | 476,585 | +39.3% | 0.00% | +50.0% |
Q1 2016 | $2,187,000 | +13.0% | 342,185 | +10.5% | 0.00% | 0.0% |
Q4 2015 | $1,936,000 | +7.0% | 309,785 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,809,000 | -29.5% | 309,785 | -0.1% | 0.00% | 0.0% |
Q2 2015 | $2,565,000 | +0.4% | 310,155 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $2,556,000 | +19.9% | 310,155 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,131,000 | +27.2% | 310,155 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $1,675,000 | -15.2% | 310,155 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $1,976,000 | +115.5% | 310,155 | +172.6% | 0.00% | +100.0% |
Q1 2014 | $917,000 | +30.8% | 113,756 | +10.7% | 0.00% | 0.0% |
Q4 2013 | $701,000 | -86.5% | 102,767 | -63.6% | 0.00% | -80.0% |
Q3 2013 | $5,199,000 | +11.0% | 282,539 | +5.5% | 0.01% | 0.0% |
Q2 2013 | $4,684,000 | – | 267,810 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
Geduld E E | 277,600 | $2,237,000 | 1.21% |
Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |